Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 9/20 | 1.00 |
| ▸ | HTR1A | P08908 | 5/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | PKM | P14618 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 0.97 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.97 |
| ▸ | GLA | P06280 | 1/20 | 0.97 |
| ▸ | APEX1 | P27695 | 1/20 | 0.97 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.97 |
| ▸ | FYN | P06241 | 1/20 | 0.68 |
| ▸ | DRD3 | P35462 | 6/20 | 0.61 |
| ▸ | HTR7 | P34969 | 4/20 | 0.61 |
| ▸ | DRD4 | P21917 | 3/20 | 0.61 |
| ▸ | DRD1 | P21728 | 2/20 | 0.61 |
| ▸ | HTR1D | P28221 | 2/20 | 0.61 |
| ▸ | DRD5 | P21918 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7749343 | 1.00 | DRD2 (1.00) | DRD2HTR1ACYP1A2CYP2D6TSHR | |
| SCHEMBL29386657 | 1.00 | DRD2 (1.00) | DRD2HTR1ACYP1A2CYP2D6TSHR | |
| SCHEMBL5658545 | 1.00 | DRD2 (1.00) | DRD2HTR1ACYP1A2CYP2D6TSHR | |
| Bromide SCHEMBL29496166 | 0.99 | DRD2 (0.97) | DRD2HTR1ACYP1A2CYP2D6TSHR | |
| Hydrochloric Acid SCHEMBL5962618 | 0.99 | LMNA (1.00) | DRD2HTR1ACYP1A2CYP2D6TSHR | |
| Bromide SCHEMBL9064205 | 0.99 | DRD2 (0.97) | DRD2HTR1ACYP1A2CYP2D6TSHR | |
| SCHEMBL14283976 | 0.90 | DRD2 (0.81) | DRD2HTR1ACYP1A2CYP2D6TSHR | |
| SCHEMBL9862321 | 0.83 | DRD2 (0.71) | DRD2HTR1ACYP1A2CYP2D6TSHR | |
| SCHEMBL15657500 | 0.83 | DRD2 (0.71) | DRD2HTR1ACYP1A2CYP2D6TSHR | |
| Hydrochloric Acid SCHEMBL9424658 | 0.82 | LMNA (0.72) | DRD2HTR1ACYP1A2CYP2D6TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2983473-A2 | PHARMACEUTICAL COMPOSITION COMPRISING AN AMPK ACTIVATOR AND A SEROTONERGIC AGENT AND METHODS OF USE THEREOF | ALS Mountain Llc (US) | 2016-02-17 | — | — | EP | claimed |
| US-20140350064-A1 | PHARMACEUTICAL COMPOSITION COMPRISING AN AMPK ACTIVATOR AND A SEROTONERGIC AGENT AND METHODS OF USE THEREOF | ALS MOUNTAIN LLC | 2014-11-27 | — | — | US | claimed |
| WO-2014144130-A2 | PHARMACEUTICAL COMPOSITION COMPRISING AN AMPK ACTIVATOR AND A SEROTONERGIC AGENT AND METHODS OF USE THEREOF | ALS MOUNTAIN LLC (US) | 2014-09-18 | — | — | WO | claimed |
| US-20120183600-A1 | NOVEL COMPOSITION FOR TREATING METABOLIC SYNDROME AND OTHER CONDITIONS | CHEN CHIEN-HUNG (US) | 2012-07-19 | — | — | US | claimed |
| EP-0760665-B1 | COMPOSITIONS CONTAINING 5HTIA AND 5HTID ANTAGONISTS | SMITHKLINE BEECHAM PLC (GB) | 2001-12-12 | — | — | EP | claimed |
| EP-0760665-A1 | COMPOSITION CONTAINING 5HT IA? and 5HT ID? ANTAGONISTS | SMITHKLINE BEECHAM PLC (GB) | 1997-03-12 | — | — | EP | claimed |
| WO-1995031988-A1 | COMPOSITION CONTAINING 5HTIA and 5HTID ANTAGONISTS | SMITHKLINE BEECHAM P.L.C. (GB) | 1995-11-30 | — | — | WO | claimed |
| US-20220323456-A1 | METHODS FOR TREATING, DIAGNOSING AND PROGNOSING A HAEMATOLOGICAL MALIGNANCY | INSTITUT DE RECERCA CONTRA LA LEUCÈMIA JOSEP CARRERAS (ES) | 2022-10-13 | — | — | US | disclosed |
| US-11337984-B2 | Methods for treating, diagnosing and prognosing a haematological malignancy | INSTITUT DE RECERCA CONTRA LA LEUCÉMIA JOSEP CARRERAS (ES) | 2022-05-24 | — | — | US | disclosed |
| US-20210228593-A1 | METHODS FOR TREATING, DIAGNOSING AND PROGNOSING A HAEMATOLOGICAL MALIGNANCY | INSTITUT DE RECERCA CONTRA LA LEUCÈMIA JOSEP CARRERAS (ES) | 2021-07-29 | — | — | US | disclosed |
| EP-3160472-B1 | METHODS FOR TREATING, DIAGNOSING AND PROGNOSING A HAEMATOLOGICAL MALIGNANCY | INST DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS (ES) | 2020-03-11 | — | — | EP | disclosed |
| US-20190343843-A1 | METHODS FOR TREATING, DIAGNOSING AND PROGNOSING A HAEMATOLOGICAL MALIGNANCY | INSTITUT DE RECERCA CONTRA LA LEUCÈMIA JOSEP CARRERAS (ES) | 2019-11-14 | — | — | US | disclosed |
| US-10195207-B2 | Methods for treating, diagnosing and prognosing a haematological malignancy | INSTITUT DE RECERCA CONTRA LA LEUCÈMIA JOSEP CARRERAS (ES) | 2019-02-05 | — | — | US | disclosed |
| US-5532264-A | POTENTIATION OF VENLAFAXINE, MILNACIPRAN AND DULOXETINE TO INCREASE AVAILABLE SEROTONIN, NOREPINEPHRINE AND DOPAMINE IN THE BRAIN BY ADMINISTERING OXYALKYLAMINE DERIVATIVES | ELI LILLY AND COMPANY (US) | 1996-07-02 | — | — | US | disclosed |
| US-5532250-A | ADMINISTERING A SEROTONIN 1A RECEPTOR ANTAGONIST: ALPRENOLOL, PINDOLOL, PROPRANOLOL, OR TERTATOLOL, WITH FLUOXETINE, VENLAFAXINE, MILNACIPRAN RO DULOXETINE | ELI LILLY AND COMPANY (US) | 1996-07-02 | — | — | US | disclosed |
| EP-0714663-A2 | Potentiation of drug response by a serotonin 1A receptor antagonist | ELI LILLY AND COMPANY (US) | 1996-06-05 | — | — | EP | disclosed |
| EP-0687472-A2 | Potentiation of drug response by a serotonin 1A receptor antagonist | ELI LILLY AND COMPANY (US) | 1995-12-20 | — | — | EP | disclosed |
| WO-1995031988-A1 | COMPOSITION CONTAINING 5HTIA and 5HTID ANTAGONISTS | SMITHKLINE BEECHAM P.L.C. (GB) | 1995-11-30 | — | — | WO | disclosed |
| WO-1995024218-A1 | SEROTONIN (5-HT1A) RECEPTOR LIGANDS AND IMAGING AGENTS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1995-09-14 | — | — | WO | disclosed |
| EP-0642787-A2 | Cessation of tobacco use | ELI LILLY AND COMPANY (US) | 1995-03-15 | — | — | EP | disclosed |